Target intelligence / Profile preview

ribosomal protein L7 pseudogene 23 (RPL7P23)

Target: RPL7P23
Molecular classification: Other (Pseudogene)

Overview

RPL7P23 is one of numerous processed pseudogenes in the human genome derived from the functional ribosomal protein L7 (RPL7) gene. Pseudogenes such as RPL7P23 do not encode a functional protein and are not known to have an active biological function or disease role. Their sequences are non-functional remnants of the parental gene and typically arise through retrotransposition of mRNA. Some RPL7 pseudogenes have been catalogued throughout the human genome, but they are not considered to be therapeutic targets and do not directly participate in cellular pathways or drug interactions[2][4][6].

Other names: RPL7_7_580RPL7P23

Beyond the preview

Go deeper on ribosomal protein L7 pseudogene 23 (RPL7P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L7 pseudogene 23 (RPL7P23).

Explore the full profile